Skip to contentX
Xenetic Biosciences, Inc.
X
XBIOXenetic Biosciences, Inc. Q1 2017 · 10-Q
Revenue—
Net Income-$2.87M-$2.87MN/M vs Q1 2016 EPS Diluted-$0.34-$0.34N/M vs Q1 2016 Operating Income-$2,855,677N/M Operating Cash Flow$280,809N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
Free Cash Flowderived$275,380N/M ended Mar 31, 2017 · filed May 15, 2017 · 45 d after period end